NCT00962065View on ClinicalTrials.gov

Study of LX4211 in Subjects With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

December 31, 2009

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

LX4211 Low Dose

A low dose of LX4211; daily oral intake for 28 days

DRUG

LX4211 High Dose

A high dose of LX4211; daily oral intake for 28 days

DRUG

Placebo

Matching placebo dosing with daily oral intake for 28 days

Trial Locations (1)

78209

Lexicon Investigational Site, San Antonio

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY